Jiangsu Beijia Pharmaceutical

Jiangsu Beijia Pharmaceutical is a pharmaceutical company based in Taizhou, China, specializing in the research, development, and manufacturing of high-end generic and innovative small molecule drugs. Established in 2015 within the China Medical City, the company focuses on therapeutic areas such as cardiovascular disease, central nervous system disorders, and oncology. Its commercial portfolio includes widely used lipid-lowering agents like Rosuvastatin and Pitavastatin. Beijia Pharmaceutical integrates advanced R&D platforms with GMP-compliant manufacturing facilities to deliver high-quality healthcare solutions. The company aims to expand its innovative pipeline while maintaining a strong presence in the high-end generics market.